CYTOSORBENTS CORPORATION Total Liabilities
CYTOSORBENTS CORPORATION (CTSO) had Total Liabilities of $38.71 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-06
- 2026-06-30: Liabilities $38.71M.
- 2026-03-31: Liabilities $38.37M.
- 2025-12-31: Liabilities $38.28M.
- 2025-09-30: Liabilities $36.73M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $38.71M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $38.37M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $38.28M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $36.73M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $36.40M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $36.24M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $36.27M 10-K · filed 2026-03-30 | $36.26M 10-K · filed 2025-03-31 |
| 2024-09-30 | $34.66M 10-K · filed 2025-03-31 | $34.80M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $36.00M 10-K · filed 2025-03-31 | $36.69M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $27.44M 10-K · filed 2025-03-31 | $28.14M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $29.48M 10-K · filed 2025-03-31 | $29.99M 10-K · filed 2024-03-15 |
| 2023-09-30 | $28.76M 10-K · filed 2025-03-31 | $29.06M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $27.98M 10-K · filed 2025-03-31 | $28.35M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $27.52M 10-K · filed 2025-03-31 | $28.51M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $27.86M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $23.13M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $23.65M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $27.84M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $26.94M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $24.46M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $23.81M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $10.22M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $10.73M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $24.05M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $24.94M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $22.91M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $23.96M 10-K · filed 2021-03-09 | |
| 2019-09-30 | $21.95M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $16.94M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $15.98M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $17.26M 10-K · filed 2020-03-05 | $15.81M 10-K · filed 2019-03-07 |
| 2018-09-30 | $14.18M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $13.38M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $13.86M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $13.84M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $12.74M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $14.17M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $9.86M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $8.36M 10-K · filed 2018-03-08 | $10.17M 10-K · filed 2017-03-03 |
| 2016-09-30 | $9.48M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $8.81M 10-Q · filed 2016-08-09 | |
| 2015-12-31 | $3.04M 10-K · filed 2017-03-03 | |
| 2013-12-31 | $3.06M 10-K · filed 2014-03-31 | |
| 2013-09-30 | $3.07M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $2.10M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $993.43K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $2.08M 10-K · filed 2014-03-31 | |
| 2012-09-30 | $2.08M 10-Q · filed 2012-11-21 | |
| 2012-06-30 | $2.30M 10-Q · filed 2012-08-13 | |
| 2012-03-31 | $2.25M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $1.80M 10-K · filed 2013-04-03 | |
| 2011-09-30 | $1.81M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $1.95M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $2.30M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |